The Week in Cancer News: Multi-cancer Detection Blood Test
An FDA committee supports a liquid biopsy that screens for up to 50 cancers, and the FDA approves a drug combo for certain people with breast cancer.
Progress Against Cancer
An FDA committee supports a liquid biopsy that screens for up to 50 cancers, and the FDA approves a drug combo for certain people with breast cancer.
Carolyn Searles and her sisters all tested positive for a BRCA1 mutation and underwent double mastectomies to reduce their breast cancer risk. Still, Carolyn was diagnosed with breast cancer while 16 weeks pregnant. Last...
The new combination is approved for patients with advanced clear cell renal cell carcinoma that progressed on or after certain immune checkpoint inhibitors. The U.S. Food and Drug Administration (FDA) has approved belzutifan (Welireg)...
Around a hundred early-career clinicians and researchers from Ukraine and Poland attended last month’s AACR on Campus event in Warsaw, held in partnership with the Maria Skłodowska-Curie National Research Institute of Oncology and the...
AACR and Kids Beating Cancer have announced a new grant to support pediatric leukemia research, with a particular focus on high-risk acute myeloid leukemia subtypes at the AACR Special Conference in Cancer Research: Bridging...
This year’s Party with a Purpose, hosted by the Friends of the AACR Foundation, will honor Robert H. Vonderheide, MD, DPhil, FAACR, and Andrew Rech, MD, PhD, of the University of Pennsylvania, for their...
The new approval is for certain patients with ER-positive, HER2-negative advanced breast cancer who have received at least one line of endocrine therapy. The U.S. Food and Drug Administration (FDA) has approved imlunestrant (Inluriyo)...
MRI surveillance for brain metastases helps preserve cognition in small cell lung cancer, and an AACR report calls for sustained research funding.
The September Editors’ Picks from AACR's peer-reviewed journals include insights into cancer evolution in leukemia, a strategy for overcoming drug resistance, the impacts of the COVID-19 pandemic on cancer care, an investigational treatment for...
Aminolevulinic acid hydrochloride is given as a topical gel in combination with light-based therapy. The U.S. Food and Drug Administration (FDA) has approved aminolevulinic acid hydrochloride (Ameluz) for the treatment of superficial basal cell...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More